Revenue: As of FY2025 Q2, the actual value is USD 1.66 B.EPS: As of FY2025 Q2, the actual value is USD 0.65.<h3>Consumer Segment</h3><ul><li>Net Sales: $930.6 million for the three months ended May 31, 2025, an increase of 2.9% compared to $904.5 million in the same period of 2024.</li><li>Operating Income: $163.6 million for the three months ended May 31, 2025, an increase of 9.6% compared to $149.3 million in the same period of 2024.</li><li>Operating Income Margin: 17.6% for the three months ended May 31, 2025, compared to 16.5% in the same period of 2024.</li></ul><h3>Flavor Solutions Segment</h3><ul><li>Net Sales: $728.9 million for the three months ended May 31, 2025, a decrease of 1.3% compared to $738.7 million in the same period of 2024.</li><li>Operating Income: $95.0 million for the three months ended May 31, 2025, an increase of 9.8% compared to $86.6 million in the same period of 2024.</li><li>Operating Income Margin: 13.0% for the three months ended May 31, 2025, compared to 11.7% in the same period of 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $161.4 million for the six months ended May 31, 2025, a decrease from $301.5 million in the same period of 2024.</li><li>Net Cash Used in Investing Activities: - $105.2 million for the six months ended May 31, 2025, compared to - $130.1 million in the same period of 2024.</li><li>Net Cash Used in Financing Activities: - $142.9 million for the six months ended May 31, 2025, compared to - $172.2 million in the same period of 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Net Sales Growth: Expected to grow between 0% and 2% in 2025 compared to 2024, with a 1% unfavorable impact from foreign currency rates.</li><li>Operating Income: Anticipated to increase by 2% to 4% over 2024 levels, including a 1% unfavorable impact from foreign currency rates.</li><li>Adjusted Operating Income: Expected to increase by 3% to 5%, including a 1% unfavorable impact from foreign currency rates.</li><li>Diluted Earnings Per Share: Projected to range from $2.98 to $3.03 in 2025, with adjusted diluted earnings per share expected to increase by 3% to 5%.</li></ul>

McCormick & Co MD | 10-Q: FY2025 Q2 Revenue: USD 1.66 B